Common numbing drug tested as potential weapon against aggressive breast cancer
NCT ID NCT07458204
Summary
This study is testing if injecting a common local anesthetic (levobupivacaine) around the tumor and nearby nerves before breast-conserving surgery can help prevent the cancer from coming back. It will involve 760 women with triple-negative breast cancer, a type known for a higher risk of recurrence. The main goal is to see if this simple addition to surgery improves the chance of being cancer-free two years later.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institut Godinot
Reims, Champagne-Ardenne, 51100, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.